Registered entities
Ambrx, Inc.
Reg. No. 571147346United States
AMBRX BIOPHARMA INC.
Reg. No. 1836056United States
Innovation
110 patent families (64 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Emerging technologies; filing pace slowing. Cited 76,156 times.
| Year | Filings |
|---|---|
| 2015 | 40 |
| 2016 | 29 |
| 2017 | 29 |
| 2018 | 22 |
| 2019 | 21 |
| 2020 | 23 |
| 2021 | 21 |
| 2022 | 18 |
| 2023 | 17 |
| 2024 | 20 |
| 2025 | 13 |
| 2026 | 6 |
Investor mix
25 investors on record; lead investors include Apricot Capital, Merck, Apposite Capital, Glynn Capital; 6 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 40% |
| Private equity | 7 | 28% |
| Accelerator & incubator | 1 | 4% |
| Other / undisclosed | 7 | 28% |